Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Veracyte (VCYT) Misses Q4 EPS by 4c, Revenues Beat; Offers 1Q Revenues Guidance Above Consensus
February 17, 2021 4:29 PM ESTVeracyte (NASDAQ: VCYT) reported Q4 EPS of ($0.15), $0.04 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $34.5 million versus the consensus estimate of $31.93 million.
For the three months ended December 31, 2020, compared to the prior year:
Total Revenue was $34.5 million, an increase of 16%;Gross Margin was 68%, an increase of 2 percentage points;Operating Expenses, Excluding Cost of Revenue, were $31.4 million, an increase of... More